Discrepancy between Angina and Ischemia Repeats in Peripheral Artery Disease

Three randomized studies showed exercising significantly improves 6-minute walk outcomes in patients with peripheral artery disease (PAD). However, many participants randomized to exercise did not perceive changes, and sometimes even got worse. 

La discrepancia entre angina e isquemia se repiten en enfermedad periférica

These findings suggest a significant discrepancy between objective and perceived change in walking ability among PAD patients.  

400 patients with peripheral artery disease randomized to exercise (n=205) vs control (n=199) completed a 6-minute walk test and a questionnaire about perceived claudication. Both tests were repeated 6 months after randomization.

Exercising improved significantly 6-minute walking distance almost 40 meters vs. baseline (p<0.001). 

Many patients perceived no improvement in walking ability after 6 months. This was true for the control group, with – 6.5 meters vs baseline (p<0.001), as opposed to the exercise group, which added 26.8 meters (p<0.001).

Another group perceived their situation had significantly worsened vs. baseline. Again, this was true for the control group, with – 27.3 meters, but not for the exercise group, with + 18.4 meters vs. baseline. 


Read also: Abdominal Aortic Aneurysm during the Pandemic: Should They Be Operated or Deferred?


Having set a walking pace, PAD patients will often report no improvement at follow up, which might tilt the scales for revascularization. It seems important to be able to objectively measure walking ability at baseline and follow up to be able to make objective decisions. 

The coronaries have shown angina and ischemia do not walk hand in hand. Now peripheral vascular disease shows similar discrepancy between symptoms and objective test outcomes. 

Conclusion

Exercising significantly improves walking distance in PAD patients. However, many patients do not perceive this change, and some even feel they get worse. 

JAHA-120-017609

Original Title: Perceived Versus Objective Change in Walking Ability in Peripheral Artery Disease: Results from 3 Randomized Clinical Trials of Exercise Therapy.

Reference: Mary M. McDermott et al. J Am Heart Assoc. 2021;10:e017609. DOI: 10.1161/JAHA.120.017609.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...

ACC 2026 | SirPAD Trial: Sirolimus-coated balloon angioplasty in infrainguinal arterial disease

Paclitaxel-coated balloons have demonstrated improved patency in peripheral arterial disease (PAD), although questions remain regarding safety and applicability across different vascular territories. In this...

ACC 2026 | HI-PEITHO: Catheter-directed strategy (EKOS) in intermediate-risk acute pulmonary embolism

The treatment of intermediate-risk pulmonary embolism (PE) continues to be an area of therapeutic uncertainty. The initial PEITHO study (2014) demonstrated a reduction in...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...